AMD/RETINA
At The American Macular Degeneration Foundation (AMDF) we have been thinking a lot about how many of you in the AMD community may be concerned about being more at-risk from COVID-19 as described by the CDC (Centers for Disease Control) and how both fears and reality may affect your decisions about maintaining your AMD care.
…
featured stories
View Conference Coverage
Take a look at some of our conference coverage, visit our roundup section.
Videos
-
Jan 22, 2020
Implantable Miniature Telescope for Advanced AMD
-
Jan 22, 2020
Treating AMD Patients with New Technology
-
Jan 22, 2020
How do you Verify That a Patient Has AMD?
-
Jan 22, 2020
Age-related Drusen or Pathologic Drusen?
-
Jan 22, 2020
What is DME?
-
Jan 22, 2020
ENTV DME Treatment Strategy
Conference Roundup
- Oct 15, 2019
Positive Efficacy Data Presented for Trial of hRPC Stem Cell Therapy
ReNeuron announced at the AAO 2019 meeting positive clinical data for its Phase 1/2a clinical trial of hRPC stem cell therapy for retinitis pigmentosa.
The ongoing trial is an open-label study to evaluate the safety, tolerability, and efficacy of…
Journal Scan
- Feb 08, 2020
Does Poor Visit Adherence Cause Vision Loss in Older Patients?
Missing just one ophthalmology appointment can cause vision loss for patients with age-related macular degeneration, highlighting the need for visit adherence, according to results from a Penn Medicine study published JAMA Ophthalmology.
Data from the Comparison of Age-related…
Trending Topics
- Mar 20, 2020
Macular Degeneration and COVID-19
At The American Macular Degeneration Foundation (AMDF) we have…
Resources
-
Eye Care Tools
- AAO Eye Wiki
- AAO Patient Education Materials
- ASRS Retina Career Center